SUMMARY Nitroprusside was used to reduce afterload in 13 patients with isolated, severe aortic regurgitation. The drug significantly lowered mean aortic pressure, pulse pressure, left ventricular end-diastolic pressure and left ventricular volume. Total ventricular, or angiographic, cardiac index was generally unaffected, but forward cardiac index was improved significantly in 8 of 13 patients. Augmentation of forward cardiac index was seen in patients with subnormal resting forward cardiac index, in patients with decidedly elevated end-diastolic pressure, and in those with depressed resting NITROPRUSSIDE has significant and favorable effects upon hemodynamics in patients with mitral regurgitation,"' 2 acute myocardial infarction,3 and chronic ischemic heart disease.4 In mitral regurgitation, the benefit arises primarily by reducing regurgitant volume and pulmonary venous pressure and by increasing forward cardiac output."2 In patients with primary muscle dysfunction, the peripheral vasodilatory properties of nitroprusside improve left ventricular function by reducing impedance to ventricular ejection resulting in improved cardiac output, stroke volume and ejection fraction. 4 We have examined the response of patients with significant aortic regurgitation to afterload reduction with nitroprusside. Detailed hemodynamic and angiographic data, obtained on patients with stable severe valvular lesions, suggest beneficial effects.
NITROPRUSSIDE has significant and favorable effects upon hemodynamics in patients with mitral regurgitation,"' 2 acute myocardial infarction,3 and chronic ischemic heart disease. 4 In mitral regurgitation, the benefit arises primarily by reducing regurgitant volume and pulmonary venous pressure and by increasing forward cardiac output."2 In patients with primary muscle dysfunction, the peripheral vasodilatory properties of nitroprusside improve left ventricular function by reducing impedance to ventricular ejection resulting in improved cardiac output, stroke volume and ejection fraction. 4 We have examined the response of patients with significant aortic regurgitation to afterload reduction with nitroprusside. Detailed hemodynamic and angiographic data, obtained on patients with stable severe valvular lesions, suggest beneficial effects.
Methods
Thirteen patients with isolated severe aortic regurgitation were studied during cardiac catheterization. Informed consent was obtained in each case. Those with evidence at the time of catheterization and angiography of significant mitral stenosis (valve area < 2.0 cm2), mitral regurgitation, or mean aortic valve gradient > 10 mm Hg were excluded. Right-sided pressures were recorded using Statham P23Db transducers and left-sided pressures using fluid-filled catheters and Micron MP-15 transducers. Forward cardiac indices (CIF) were determined using the Fick method or duplicate indicator dilution curves using indocyanine green dye, injected into the pulmonary artery and sampled in the descending aorta. Pressures and gradients were computerdetermined5 and manually checked. Resting ventriculography was performed in the 30°right anterior oblique projection, and ventricular volumes and ejection fraction were determined using a video-disc light-pen computer system.6 Fifteen minutes after angiography, sodium nitroprusside . 2) . However, two patients (# 10 and I 1) exhibited increases of left ventricular cardiac index greater than 20%. These responses were caused by an increased stroke index and ejection fraction. It is possible that in some cases nitroprusside resulted in obliteration of ventricular margins by trabeculations in such a way that the end-systolic volume is underestimated. Two patients (#8 and 12) showed declines in CILV greater than 20%. In both patients, right atrial pressure was severely reduced by nitroprusside (3 to 0 mm Hg; 12 to 2 mm Hg), as was left ventricular end-diastolic pressure (7 to 2 mm Hg; 23 to 6 mm Hg). Both patients experienced pronounced shrinkage of end-diastolic volume suggesting that the fall in ventricular output in these two patients was probably due to a disproportionate decline in venous return to the heart. Forward cardiac index (CIF) was significantly increased from 2.4 L/min/m2 to 2.8 L/min/m2 (P < 0.05) ( fig. 3) 
Nine patients had a subnormal resting forward output (< 2.5 L/min/m2), six of whom improved with nitroprusside ( fig. 3 ). Of the six who increased, CIF was elevated into the normal range in four patients. With the exception of patient 5, the most favorable results in improving CIF were in those patients with decidedly elevated left ventricular enddiastolic pressures which were brought into the normal range (7-12 mm Hg). Afterload reduction in patients with initially normal ventricular filling pressures did not benefit, or even worsened, forward output. In summary, an improvement in CIF may be anticipated if the resting CIF is subnormal and if resting left ventricular end-diastolic pressure is significantly elevated.
By virtue of the reduced systolic pressure, total (LV) stroke work index and minute work index were reduced in all 13 patients (P <0.01; table 1). Hence, for 12 of 13 patients, forward cardiac index was increased or maintained at a time when the ventricle performed significantly less work.
Ventriculographic Measurements
Regurgitant volume during nitroprusside infusion was decreased in six patients, unchanged in six and increased in one patient. Regurgitant fraction, which reflects changes in both left ventricular and forward output, fell significantly in six patients and remained essentially unchanged in the remaining seven. In four of the six patients in whom regurgitant fraction fell, the forward output improved. In three of the six, the decrease in regurgitant volume came about primarily as a result of a decrement in CILv. There were no identifiable hemodynamic differences (resting end-diastolic volume, left ventricular end-diastolic pressure, regurgitant fraction, or degree of afterload reduction) between those who decreased regurgitation and those who did not. Left ventricular end-diastolic volume was decreased by more than 10% during nitroprusside in 8 of 13 patients and remained unchanged in four (fig. 4) . Neither the initial ventricular volume nor the magnitude of afterload reduction seemed to predict the magnitude of end-diastolic volume diminution. Stroke volume remained unchanged in eight patients, increased in two and fell in three. Ejection fraction rose by .10 or more in five patients with a significant overall increase (.53 to .59, P < 0.05) (fig. 5 ). Both patients with markedly depressed resting ejection fraction (#4 and 1 1) experienced improvement. Forward cardiac output improved in five of the six patients who increased ejection fraction, and end-diastolic volume fell significantly in five of these six. However, there seemed to be no other features to identify these six patients who improved ejection fraction as compared with the group which did not.
Discussion
Few data are available on the effects of afterload reduction on hemodynamics in patients with aortic regurgitation. The observation that the Austin-Flint murmur softens after amyl nitrite inhalation has been taken as evidence that regurgitation is lessened by lowered blood pressure. 7 Delius and Enghoff found that the administration of amyl nitrite in patients with aortic regurgitation resulted in a decrease in mean arterial pressure, a diminution in left ventricular enddiastolic pressure, and an increase in effective stroke volume in most cases. 3) . Thus, the improvement in forward output was accomplished either by an increase in ejection fraction or decrease in regurgitant fraction or combination of both. However, the total or left ventricular cardiac index is usually unaffected by afterload reduction ( fig. 2 ), a result that is consistent with previous studies showing that total cardiac output in patients with severe aortic regurgitation is little affected by exercise. 9 The consistent reduction in left ventricular stroke work index and minute work index coupled with general improvement in forward cardiac index translate into improved myocardial oxygen supply/demand ratio. The reduction in ventricular size following nitroprusside would also tend to lessen myocardial oxygen requirements by reducing wall tension."0 Nitroprusside would be expected to benefit the relationship of myocardial oxygen delivery to requirements.
The improved ejection fraction after nitroprusside in patients with markedly depressed resting ejection fractions is consistent with the results observed in cardiomyopathy patients, with or without regurgitant lesions." I In patients with chronic ischemic heart disease and failure, depressed ejection fractions almost invariably respond to nitroprusside.1' ' Similar results were found in studying patients with chronic mitral regurgitation.' 2 Our data in patients with chronic aortic regurgitation confirm that those individuals who exhibit left ventricular dysfunction at rest, as manifested by a depressed resting ejection fraction, will tend to benefit from afterload reduction.
The regurgitant volume did not consistently decline following nitroprusside which contrasts with the uniform fall in regurgitation in patients with mitral regurgitation. A possible explanation is that the diastolic aortic-to-leftventricular gradient is not always greatly altered by nitroprusside. Our data show that aortic diastolic pressure is less affected than systolic pressure. These observations probably account for the variability in degree of regurgitation with afterload reduction in patients with aortic insufficiency.
Clinical Implications These data support the feasibility of using afterload reduction in patients with severe aortic regurgitation to assist in the temporary treatment of severe congestive failure or inadequate peripheral perfusion, unresponsive to an adequate trial of digitalis and diuretics. The patient likely to benefit from afterload reduction would, in general, have the following characteristics: 1) depressed forward cardiac index; 2) distinctly elevated left ventricular end-diastolic pressure; 3) reduced ejection fraction; and 4) elevated arterial systolic pressure. Careful monitoring of aortic pressure and pulmonary artery wedge pressure would be advisable to assure that excessive reduction in left ventricular filling pressure is not produced. The advantages in such patients would be decreased ventricular size, augmentation of forward stroke index and decreased stroke and minute work index.
By inference, these data provide a rationale for control of systolic blood pressure in patients with chronic aortic regurgitation. The effects of a smaller ventricular volume, possibly decreased regurgitant fraction and lowered ventricular work would seem beneficial in order to delay progressive ventricular dysfunction in patients with aortic regurgitation.
